BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2736215)

  • 1. Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood.
    de Vathaire F; François P; Hill C; Schweisguth O; Rodary C; Sarrazin D; Oberlin O; Beurtheret C; Dutreix A; Flamant R
    Br J Cancer; 1989 May; 59(5):792-6. PubMed ID: 2736215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study.
    Guérin S; Guibout C; Shamsaldin A; Dondon MG; Diallo I; Hawkins M; Oberlin O; Hartmann O; Michon J; Le Deley MC; de Vathaire F
    Int J Cancer; 2007 Jan; 120(1):96-102. PubMed ID: 17013899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment.
    Rubino C; de Vathaire F; Shamsaldin A; Labbe M; Lê MG
    Br J Cancer; 2003 Sep; 89(5):840-6. PubMed ID: 12942115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood.
    Le Vu B; de Vathaire F; Shamsaldin A; Hawkins MM; Grimaud E; Hardiman C; Diallo I; Vassal G; Bessa E; Campbell S; Panis X; Daly-Schveitzer N; Lagrange JL; Zucker JM; Eschwège F; Chavaudra J; Lemerle J
    Int J Cancer; 1998 Jul; 77(3):370-7. PubMed ID: 9663598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment.
    de Vathaire F; Hawkins M; Campbell S; Oberlin O; Raquin MA; Schlienger JY; Shamsaldin A; Diallo I; Bell J; Grimaud E; Hardiman C; Lagrange JL; Daly-Schveitzer N; Panis X; Zucker JM; Sancho-Garnier H; Eschwège F; Chavaudra J; Lemerle J
    Br J Cancer; 1999 Apr; 79(11-12):1884-93. PubMed ID: 10206309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
    J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood.
    Kony SJ; de Vathaire F; Chompret A; Shamsaldim A; Grimaud E; Raquin MA; Oberlin O; Brugières L; Feunteun J; Eschwège F; Chavaudra J; Lemerle J; Bonaïti-Pellié C
    Lancet; 1997 Jul; 350(9071):91-5. PubMed ID: 9228960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation dose as a risk factor for malignant melanoma following childhood cancer.
    Guérin S; Dupuy A; Anderson H; Shamsaldin A; Svahn-Tapper G; Moller T; Quiniou E; Garwicz S; Hawkins M; Avril MF; Oberlin O; Chavaudra J; de Vathaire F
    Eur J Cancer; 2003 Nov; 39(16):2379-86. PubMed ID: 14556931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
    Nguyen F; Rubino C; Guerin S; Diallo I; Samand A; Hawkins M; Oberlin O; Lefkopoulos D; De Vathaire F
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):908-15. PubMed ID: 18262102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma.
    Xu Y; Wang H; Zhou S; Yu M; Wang X; Fu K; Qian Z; Zhang H; Qiu L; Liu X; Wang P
    Leuk Lymphoma; 2013 Jul; 54(7):1396-404. PubMed ID: 23101661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignant neoplasms after treatment of childhood cancer.
    Klein G; Michaelis J; Spix C; Wibbing R; Eggers G; Ritter J; Kaatsch P
    Eur J Cancer; 2003 Apr; 39(6):808-17. PubMed ID: 12651207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries.
    Garwicz S; Anderson H; Olsen JH; Døllner H; Hertz H; Jonmundsson G; Langmark F; Lanning M; Möller T; Sankila R; Tulinius H
    Int J Cancer; 2000 Nov; 88(4):672-8. PubMed ID: 11058888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignant neoplasms in patients treated for Hodgkin's disease with radiotherapy or radiotherapy and chemotherapy.
    Nelson DF; Cooper S; Weston MG; Rubin P
    Cancer; 1981 Dec; 48(11):2386-93. PubMed ID: 7296488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second malignant neoplasms in patients treated for childhood leukemia. A population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO).
    Nygaard R; Garwicz S; Haldorsen T; Hertz H; Jonmundsson GK; Lanning M; Moe PJ
    Acta Paediatr Scand; 1991 Dec; 80(12):1220-8. PubMed ID: 1785295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Radiation Dose and Other Risk Factors of Thyroid Carcinoma Following Childhood Cancer.
    de Vathaire F; Haddy N; Allodji RS; Hawkins M; Guibout C; El-Fayech C; Teinturier C; Oberlin O; Pacquement H; Diop F; Kalhouche A; Benadjaoud M; Winter D; Jackson A; Bezin Mai-Quynh G; Benabdennebi A; Llanas D; Veres C; Munzer M; Nguyen TD; Bondiau PY; Berchery D; Laprie A; Deutsch E; Lefkopoulos D; Schlumberger M; Diallo I; Rubino C
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4282-90. PubMed ID: 26327481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignant neoplasms in children: an update from the Late Effects Study Group.
    Meadows AT; Baum E; Fossati-Bellani F; Green D; Jenkin RD; Marsden B; Nesbit M; Newton W; Oberlin O; Sallan SG
    J Clin Oncol; 1985 Apr; 3(4):532-8. PubMed ID: 2984346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
    van Leeuwen FE; Klokman WJ; Stovall M; Hagenbeek A; van den Belt-Dusebout AW; Noyon R; Boice JD; Burgers JM; Somers R
    J Natl Cancer Inst; 1995 Oct; 87(20):1530-7. PubMed ID: 7563187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary malignant neoplasms following radiotherapy for primary cancer in children and young adults.
    Harbron RW; Feltbower RG; Glaser A; Lilley J; Pearce MS
    Pediatr Hematol Oncol; 2014 Apr; 31(3):259-67. PubMed ID: 24087931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2nd malignant tumors in children. Study of 38 cases].
    Oberlin O; Bernard A; Flamant F; Hartmann O; Kalifa C; Patte C; Sarrazin D; Tournade MF; Lemerle J
    Arch Fr Pediatr; 1984 Apr; 41(4):241-8. PubMed ID: 6477040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.